BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$2.11B |
| 2 |
Veralto
VLTO
|
+$1.29B |
| 3 |
Blackstone
BX
|
+$1.1B |
| 4 |
Extra Space Storage
EXR
|
+$964M |
| 5 |
Airbnb
ABNB
|
+$935M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.47B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$1.29B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$1.09B |
| 5 |
NVIDIA
NVDA
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Healthcare | 13.55% |
| 3 | Financials | 11.73% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
GH Research
GHRS
$1.93B
| $245K | ﹤0.01% |
24,364
+9,548
| +64% | +$110K |
|
4402
BioVie
BIVI
$11.5M
| $245K | ﹤0.01% |
717
-209
| -23% | -$81.7K |
|
4403
First Seacoast Bancorp
FSEA
$79.6M
| $245K | ﹤0.01% |
33,134
-2,277
| -6% | -$17.4K |
|
|
SJT
4404
San Juan Basin Royalty Trust
SJT
$117M
| $244K | ﹤0.01% |
35,231
+3,459
| +11% | +$24.9K |
|
|
CYT
4405
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $243K | ﹤0.01% |
85,584
-2,823
| -3% | -$7.78K |
|
4406
Focus Universal
FCUV
$8.15M
| $243K | ﹤0.01% |
313
-31
| -9% | -$22K |
|
4407
Spyre Therapeutics
SYRE
$8.54B
| $242K | ﹤0.01% |
19,768
-1,388
| -7% | -$18.3K |
|
4408
Hanover Bancorp
HNVR
$188M
| $240K | ﹤0.01% |
13,257
+919
| +7% | +$16.7K |
|
|
CIZN
4409
DELISTED
Citizens Holding Co.
CIZN
| $238K | ﹤0.01% |
22,645
-411
| -2% | -$4.47K |
|
4410
AquaBounty Technologies
AQB
$4.66M
| $236K | ﹤0.01% |
49,357
-278
| -0.6% | -$1.65K |
|
|
ONCT
4411
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $236K | ﹤0.01% |
39,284
-11
| -0% | -$77 |
|
|
JMIA
4412
Jumia Technologies
JMIA
$737M
| $235K | ﹤0.01% |
88,843
-15,953
| -15% | -$55.2K |
|
4413
First National Corp
FXNC
$287M
| $234K | ﹤0.01% |
13,311
-4,227
| -24% | -$72.1K |
|
4414
KALA BIO
KALA
$14.1M
| $232K | ﹤0.01% |
522
-4
| -0.8% | -$2.63K |
|
4415
Oramed Pharmaceuticals
ORMP
$167M
| $232K | ﹤0.01% |
88,798
-9,232
| -9% | -$29.1K |
|
|
SOS
4416
SOS Limited
SOS
$16.6M
| $232K | ﹤0.01% |
+3,526
| New | +$264K |
|
4417
Nomad Foods
NOMD
$1.66B
| $229K | ﹤0.01% |
15,035
-29,393
| -66% | -$508K |
|
|
GMDA
4418
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $228K | ﹤0.01% |
220,875
+27,150
| +14% | +$34.7K |
|
|
SIEN
4419
DELISTED
Sientra, Inc.
SIEN
| $227K | ﹤0.01% |
81,613
-11,501
| -12% | -$35.4K |
|
4420
Ocean Power Technologies
OPTT
$48.9M
| $226K | ﹤0.01% |
580,571
| – | – |
|
|
SUNW
4421
DELISTED
Sunworks, Inc.
SUNW
| $226K | ﹤0.01% |
435,323
-515
| -0.1% | -$553 |
|
4422
Achieve Life Sciences
ACHV
$659M
| $226K | ﹤0.01% |
52,585
| – | – |
|
4423
Vanguard Real Estate ETF
VNQ
$39.2B
| $225K | ﹤0.01% |
2,974
+320
| +12% | +$26.4K |
|
|
ASTR
4424
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $224K | ﹤0.01% |
121,348
-164
| -0.1% | -$712 |
|
4425
Lipocine
LPCN
$17.5M
| $223K | ﹤0.01% |
74,846
-5,452
| -7% | -$22.9K |
|
Similar funds
BlackRock's Q3 2023 Portfolio in Review
As of Q3 2023, BlackRock held 5,656 positions worth $3.48T, down 4.1% from $3.63T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q3 2023 filing shows 156 new, 2,077 increased, 2,595 reduced and 210 closed positions. Its largest new stake was Veralto: 15,466,356 shares worth $1.31B. The largest sale was Johnson & Johnson, an estimated $2.47B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2023 buy was Veralto: 15,466,356 shares worth $1.31B.
- BlackRock added most to Kenvue in Q3 2023, an estimated $2.11B increase.
- BlackRock's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $2.47B.
- BlackRock fully exited Life Storage, Inc. in Q3 2023, selling an estimated $1.29B.
- BlackRock's ten largest holdings make up 22% of its $3.48T portfolio in Q3 2023.
- BlackRock opened 156 new positions and closed 210 in Q3 2023.
- BlackRock's portfolio value fell 4.1% quarter-over-quarter to $3.48T.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.